Exogenous Addition of a C-Xylopyranoside Derivative Stimulates Keratinocyte Dermatan Sulfate Synthesis and Promotes Migration by Muto, Jun et al.
Exogenous Addition of a C-Xylopyranoside Derivative
Stimulates Keratinocyte Dermatan Sulfate Synthesis and
Promotes Migration
Jun Muto
1, Nandita Natasha Naidu
2, Kenshi Yamasaki
1, Nathalie Pineau
3, Lionel Breton
3., Richard L.
Gallo
1*
.
1Division of Dermatology, University of California, San Diego and Veterans Affairs San Diego Health Care System, San Diego, California, United States of America,
2Glycotechnology Core Resource, University of California, San Diego, California, United States of America, 3L’Ore ´ al Recherche, Clichy, France
Abstract
As C-Xyloside has been suggested to be an initiator of glycosaminoglycan (GAG) synthesis, and GAGs such as Dermatan
sulfate (DS) are potent enhancers of fibroblast growth factor (FGF) - 10 action, we investigated if a C-Xylopyranoside
derivative, (C-b-D-xylopyranoside-2-hydroxy-propane, C-Xyloside), could promote DS production by cultured normal human
keratinocytes, how this occurs and if C-Xyloside could also stimulate FGF-dependent cell migration and proliferation. C-
Xyloside-treated keratinocytes greatly increased secretion of total sulfated GAGs. Majority of the induced GAG was
chondroitin sulfate/dermatan sulfate (CS/DS) of which the major secreted GAG was DS. Cells lacking xylosyltransferase
enzymatic activity demonstrated that C-Xyloside was able to stimulate GAG synthesis without addition to core proteins.
Consistent with the observed increase in DS, keratinocytes treated with C-Xyloside showed enhanced migration in response
to FGF-10 and secreted into their culture media GAGs that promoted FGF-10-dependent cellular proliferation. These results
indicate that C-Xyloside may enhance epithelial repair by serving as an initiator of DS synthesis.
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Introduction
Proteoglycans (PG) and their glycosaminoglycan (GAG) chains
are essential factors in skin growth and development and are
thought to act during wound repair to influence growth factor
functions [1]. Dermatan sulfate (DS) is the most common GAG in
the skin and is estimated to comprise between 36 and 78% of the
sulfated GAG in wound fluid [1]. GAGs, such as DS, and their PG
core proteins, participate in a variety of functions during wound
healing including binding multiple growth factors and promoting
their activities [1,2,3,4,5,6,7,8]. Of these activities, members of the
fibroblast growth factor (FGF) family, including FGF-7 and FGF-
10, depend on GAGs to participate in important wound repair
events including inflammation, repair and regeneration [9] [10].
Because of the important role of GAGs in skin biology, mechanisms
to control production or breakdown are potentially clinically
important.
Of the several GAGs in wounds, DS has been shown to be a
potent enhancer of the action of FGF-7 and -10, and is vital for
wound repair [11]. DS consists of repeating disaccharide units
of N-acetylgalactosamine and glucuronic acid (GlcA)-linked
b1R4a n db1R3, respectively. Similar to modifications that
occur in heparin and heparan sulfate (HS), but unlike the other
chondroitin sulfates (CS), the GlcA of DS undergoes epimeriza-
tion of the C-5 carbon, resulting in iduronic acid (IdoA). These
structural characteristics of DS make it unique since it resembles
some elements of the well studied HS, but yet is considered a
CS.
Xylose (Xyl) is a unique component of PGs and is the first
sugar attached to the nascent PG core protein when the
posttranslational assembly of GAG side chains is initiated.
During transport through the secretory pathway, GAG chains
are polymerized on the common linkage region GlcUA-Gal-
Gal-Xyl-protein. This saccharide serves as a primer for either
chondroitin sulfate (CS) type or heparan sulfate (HS) type GAG
chain synthesis. Biosynthesis of GAG chains can also be
accomplished in an alternative manner, in the absence of core
proteins, by using xylosides as primers. b-Xylosides initiate GAG
synthesis by serving as acceptors in the first galactosylation step
[12]. The type of GAG produced using this technique depends on
the structure of the aglycone.
In the present study, we set out to determine if increased GAG
synthesis could be stimulated in keratinocytes and to test the
hypothesis that C-Xyloside could do this by serving as an
initiator of GAG synthesis and thus improve FGF-10-mediated
responses.
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C-Xyloside induces the release of sulfated GAGs from
keratinocytes
To investigate how C-Xyloside might work on the skin, we
studied if it could serve as an initiator of GAG synthesis by
cultured normal human epidermal keratinocytes (NHEK). Cells
were treated with or without C-Xyloside and the amount of
sulfated GAGs in the media and cell lysates measured. A time-
dependent increase in sulfated GAGs was observed in the culture
media of NHEK, with a mean value of 8.0 mg/ml 24 hours after
1 mM C-Xyloside treatment, and 10.6 mg/ml 48 hours after
1 mM C-Xyloside treatment (Figure 1A). The concentration of
sulfated GAGs in cell lysates was also measured after 0.3 mM and
1 mM C-Xyloside treatment, and normalized to cell number. The
concentrations in cell lysates after C-Xyloside treatments were
within the normal range set by vehicle-treated control cells (data
not shown). Treatment of NHEK with doses of C-Xyloside
ranging from 0.1 to 10 mM increased the amount of sulfated
GAGs in culture media but sulfated GAGs were not detectable in
the media of keratinocytes treated at a concentration lower than
10 mM (Figure 1B). In contrast, treatment of 12F fibroblasts with
1 mM C-Xyloside showed that the amount of secreted GAGs in
the media from fibroblasts was much less than the amount of
GAGs from NHEK culture media after treatment (data not
shown). These findings demonstrated that keratinocytes treated
with C-Xyloside are stimulated to secrete and increase the
abundance of sulfated GAGs in the media.
C-Xyloside induces xylosyltransferase-deficient mutant
CHO-745 cells to synthesize and secrete sulfated GAGs
To determine if the GAG produced by treatment with C-
Xyloside was free GAG or GAG associated with a proteoglycan
core, the involvement of the xylosyltransferase enzyme in syn-
thesizing and secreting sulfated GAGs was examined by using
CHO-745 cells, a xylosyltransferase-deficient mutant CHO cell line
that has less than 5% of the xylosyltransferase activity found in wild-
type CHO-K1 cells [13]. Xylosyltransferase is necessary for GAG
formation on core protein of proteoglycaan, therefore new GAG
synthesis observed in these cells would indicate C-Xyloside was
serving as the accepter of GAG chain elongation and thus
substituting for core protein. CHO-K1 cells were treated with C-
Xyloside and incubated for 24 and 48 hours, and total sulfated
GAGs were determined. CHO-745 cells produced slightly more
total sulfated GAGs compared to CHO-K1 cells (Figure 1C). Thus,
sulfated GAG synthesis induced by C-Xyloside was independent of
xylosyltransferase, suggesting that the majority of GAGs produced
after C-Xyloside stimulation were free GAGs synthesized without
core proteins. Supporting this conclusion, C-Xyloside also did not
increase mRNA expression of enzymes involved in CSsynthesisand
secretion of sulfated proteoglycans such as: CS synthase 1 (CSS1),
CSS2, CSS3,chondroitin sulfate glucuronyltransferase(CSGlcAT),
chondroitin sulfate N-acetylgalactosaminyltransferase1(CSGal-
NAcT1) and CSGalNAcT2 (data not shown).
Analysis of GAGs secreted from NHEK after treatment
with C-Xyloside
The amount, composition, and sulfation patterns of GAGs
are essential variables that influence cellular behaviors during
development, coagulation, and wound repair [14]. We therefore
sought to characterize the sulfated GAGs produced by NHEK
treated with C-Xyloside. First, conditioned culture media containing
secreted GAG from treated keratinocytes was treated with nitrous
acid (to fragment HS) or chondroitinase ABC (to digest CS/DS).
Most of total GAGs were digested by chondroitinase ABC, but none
by nitrous acid, demonstrating that the majorityof the sulfated GAG
produced by NHEK treated with C-Xyloside was CS, not HS.
Figure 1. C-Xyloside induces sulfated GAGs from NHEK in
culture media without the involvement of Xylosyltransferase.
Primary keratinocytes were stimulated with PBS (untreated cells) or C-
Xyloside (0.3 mM or 1 mM). (A) Cultured media were collected after 24
and 48 hours. Total sulfated GAG was determined by Blyscan assay. (B),
Increasing concentrations of C-Xyloside were added to keratinocytes.
Culture media was collected after 24 hours and total sulfated GAG was
determined by Blyscan assay. (C), CHO-K1 (black bars) and CHO-745
(white bars) cells were cultured in the presence or absence of C-
Xyloside (1 mM) for 24 hours and the amount of sulfated GAG in the
media was determined by Blyscan assay. Data are representative of
three individual experiments, and presented as mean 6 SEM (n=3).
N.D., not detected.
doi:10.1371/journal.pone.0025480.g001
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conditioned culture media revealed that GAGs produced by
NHEK had 70.4% GalNH2, 20.9% GlcA and 8.69% IdoA, which
is compatible with DS (CS-B) (Figure 2). Analysis of these same
samples by Mass Spectrometry confirmed the existence of IdoA, a
unique component only found in DS or HS. Analysis of
disaccharide composition by using reverse phase ion pair chromatog-
raphy, revealed that most of the secreted GAGs were sulfated
(Figure 3A, B). Quantification of disaccharides was achieved using an
aniline tagging method and mass spectrometry as described [15].
D0a4 was 36.7%, D0a6 was 57.4%, and D0a10 was 2.42%
(Figure 3C) [16]. Thus, these data taken together show c-Xyloside
induces NHEK to produce a sulfated GAG that is predominantly DS.
C-Xyloside improves the capacity of FGF-10 to promote
keratinocyte migration
Given that C-Xyloside could induce an increase in DS, and that
DS can enable enhanced function of FGF-10, we next hypoth-
esized that C-Xyloside might increase NHEK responsive-
ness to FGF-10, thus providing a potential explanation for the
effects observed in vivo. Treatment with a combination of both C-
Xyloside and FGF-10 enhanced NHEK migration compared to
treatment with C-Xyloside or FGF-10 alone (Figure 4A, B). This
effect was similar to results seen following stimulation with
exogenously added DS plus FGF-10, a treatment previously
shown to enhance keratinocyte migration.
Conditioned media from keratinocytes treated with C-
Xyloside facilitates FGF-10-dependent cell proliferation
Since BaF3/KGFR cells express FGFR2-IIIb constitutively and
proliferate in a FGFR2-IIIb-dependent manner, BaF3/KGFR cells
havebeen usedasa model systemtospecifically studythe interaction
between FGFR2-IIIb and FGF-10. C-Xyloside (1 mM) itself did not
facilitate BaF3/KGFR cell proliferation in the presence of FGF-10
(data not shown). Conditioned media from keratinocytes treated
with or without C-Xyloside was then used to stimulate BaF/KGFR
cells in the presence of FGF-10. Media from keratinocytes treated
with C-Xyloside enhanced BaF3/KGFR cell proliferation only in
the presence of FGF-10, and similar to the enhancement seen with
DS (Figure 4C). These results further support observations that
NHEK treated with C-Xyloside releases DS and has functional
significance in terms of growth factor response.
Discussion
In the present study, we show that a C-xylopyranoside de-
rivative can act as a potent stimulus for increased synthesis of DS by
keratinocytes and enables enhanced FGF-10 responsiveness. This is a
potentially critical developmental function as FGF-10 is essential for
epithelial development and wound repair. This was clearly shown in
results from FGFR2-IIIb null mice which exhibit severe develop-
mental malformations in cardiac [17], limb [18], bone [19], lung,
tooth, and thymic [20] development. These mice also display severe
epidermal hypoplasia within basal keratinocytes, demonstrating the
important role for this receptor, and its ligand FGF-10, in
keratinocyte migration, proliferation, and differentiation [21].
The function of FGF-10 is dependent, at least in part, upon
cutaneous DS produced during injury [11]. The purpose of this study
was to test the hypothesis that a C-xylopyranoside derivative could
induce the production of GAGs such as DS from human
keratinocytes, and thus influence functions dependent on DS.
Measurement of soluble GAGs in culture media from keratinocytes
demonstrated that large amounts ofsulfated GAGswere present in the
media after C-Xyloside treatment. This GAG was not heparan sulfate
since most of the soluble GAG was digested only by chondroitinase
ABC. Furthermore, the GAGs synthesized by C-Xyloside addition
included IdoA residues and were highly sulfated, containing more
than 35% of D0a4. This indicated that the newly synthesized GAG
was DS and contained the specific sulfation which has optimal activity
for enabling FGF function [2]. Therefore, although we can not
exclude the possibility that some additional HS and CS was produced
by these cells, a large proportion of the total GAG released by NHEK
was probably a biologically active form of DS.
To confirm that the DS produced was indeed biologically
active, we performed an in vitro scratch assay. This showed that C-
Xyloside augmented the ability of keratinocytes to migrate, a
critical process required for optimal wound repair, and a process
also enhanced by DS. Furthermore, by using FGFR2-IIIb
expressing cells, we showed that C-Xyloside itself did not facilitate
cell proliferation, nor did it induce growth factor release, but
rather induced a molecule that could only stimulate proliferation
in the presence of FGF-10. Combined, this is strongly suggestive
that C-Xyloside treatment of keratinocytes results in production of
DS, and that this facilitates the action of FGF-10.
The significance of the current observations to skin biology is
several-fold. First, we show here for the first time a biochemical
strategy to alter GAG synthesis by keratinocytes. As GAGs are
critical components of the extracellular matrix of the skin, and
these molecules function in a variety of ways that range from
establishing structural integrity to modifying growth factor and
enzymatic function, a simple and direct system to enhance GAG
Figure 2. Monosaccharide composition analysis of GAGs
release by NHEKs. Media were harvested after 24 hours of culture
(A) without or (B) with C-Xyloside (1 mM) stimulation and monosac-
charide compositions were analyzed by HPAEC chromatograph as
described under ‘materials and methods’. The peak at 17 min may
represent a monosaccharide such as glucose in the media (Glc). Arrows
indicate the retention time for galactosamine (GalNH2), glucuronic acid
(GlcA), and iduronic acid (IdoA). PAD: pulsed amperometric detection;
nC: nano-coulomb. Data are representative of three individual
experiments.
doi:10.1371/journal.pone.0025480.g002
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under the experimental conditions used here, keratinocytes appear
primed to initiate DS above other GAGs. This supports prior work
suggesting DS has unique importance in the skin and may in fact be
more relevant to growth factor responses than the much more widely
studied GAG HS. Thus, in future studies it would be of interest to
evaluate in vivo the responses to topical application C-Xyloside to
determine if this might augment the activity of growth factors such as
FGF-10 to promote wound repair or enhance epidermal growth.
This novel approach suggests a strategy to enhance endogenous
growth factor activity in abnormal wound repair without the limiting
expense of delivery of excess recombinant proteins.
Materials and Methods
Reagents
DS from porcine intestinal mucosa (DS-03122) was purchased
from Celsus Laboratories Inc. (Cincinnati, OH). Chondroitinase
Figure 3. Disaccharide analysis of synthesized GAGs. Media were harvested after 24 hours of culture (A) without or (B) with C-Xyloside (1 mM)
stimulation. GAG in culture media were digested with chondroitinase ABC and the disaccharides were resolved by anion-exhange HPLC with post-
column derivitization and fluorescence detection (see materials and methods.) Values are expressed as molar percentage. Data are representative of
three individual experiments. (C), the disaccharides were resolved by Glycan reductive isotope labeling/mass spectrometry (n=2). Data are presented
as mean 6 range. D0a0, DUA-GalNAc; D0a4, DUA-GalNAc4S; D2a0, DUA2S-GalNAc; D0a6, DUA-GalNAc6S; D2a4, DUA2S-GalNAc4S; D2a6, DUA2S-
GalNAc6S; D0a10, DUA-GalNAc4S6S; D2a10, DUA2S-GalNAc4S6S. DUA=4, 5-unsaturated uronic acid.
doi:10.1371/journal.pone.0025480.g003
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Recombinant FGF-10 was purchased from R&D Systems (Minne-
apolis, MN). C-b-D-xylopyranoside-2-hydroxy-propane (C-Xylo-
side) was synthesized by L’Ore ´al Research Laboratories (France).
Cell culture
Normal human epidermal keratinocytes (Invitrogen, Gibco Cell
Culture, Portland, OR) were grown to 80% confluence in EpilifeH
medium containing 0.06 mM Ca
2+, Epilife defined growth
supplement (EDGS) (Invitrogen, Gibco Cell Culture), 50 U/ml
penicillin, and 50 mg/ml streptomycin at 37uC in a humidified
atmosphere of 5% CO2. The human primary foreskin fibroblasts
cell line 12F were provided by Advanced Tissue sciences (La Jolla,
CA) and were grown in Dulbecco’s modified Eagle’s medium
(DMEM; Gibco BRL, Rockville, MD) supplemented with 10%
fetal bovine serum (HyClone, Logan, UT), L-glutamine, penicillin
and streptomycin. CHO-K1 cell lines were obtained from
American Type Culture Collection (Manassas, VA). A mutant
CHO cell line pgsA-745 (designated here as CHO-745) [13] were
kind gift from Prof. J.D. Esko (University of California, San Diego,
CA).
Cell treatment with C-Xyloside, and glycosaminoglycan
quantitation
Cells, grown to 80% confluence in media, were incubated with
0, 0.3, 1 mM of C-Xyloside for 24 or 48 hours. The cultured
media were harvested. Sulfated GAG in the form of PG or free
GAG chains was purified from the cell lysates as previously
described [1]. Total sulfated PG/GAG was quantified using
Blyscan assay according to the manufacturer’s instructions
(Accurate Chemical Science Corp., Westbury, NY). Blyscan assay
is a quantitative dye-binding method for analysis of sulfated
GAGs.
Disaccharide Analysis and Uronic acid determination,
HPAEC-PAD
The Glycotechnology Core at the University of California, San
Diego, performed all disaccharide analyses. For uronic acid
determination, the GAG samples were treated with 2 M TFA at
100uC for 6 hours to cleave all glycosidic linkages. After drying the
hydrolyzate, samples were dissolved in water and analyzed by
HPAEC-PAD using a CarboPac PA-1 column. Common uronic
acid standards (Glucuronic, Galacturonic and iduronic acids) were
treated in parallel and used for calibration of HPAEC-PAD
response.
For disaccharide analysis, the GAG samples were digested
completely using chondroitinase ABC. The analysis and separa-
tion of disaccharides were achieved by using reverse phase ion pair
chromatography (C18 TosoHaas ODS-120T column, 4 um
particle size), with post-column derivation based on the method
described previously by Sakai et al [22]. We also carried out Mass
spectrometry using glycan reductive isotope labeling as described
Figure 4. C-Xyloside promotes FGF-10 dependent keratinocyte migration and cell proliferation. (A), Primary keratinocytes were
stimulated with DS alone, C-Xyloside (CX) alone, FGF-10 alone, C-Xyloside and FGF-10 combined, DS and FGF-10 combined or vehicle. Data are
plotted as the mean 6 SEM of three individual experiments with samples in quadruplicate. *, p,0.05 (B), Identical fields were photographed 0 and
24 hours after wounding. (C), Primary keratinocytes were treated with PBS or C-Xyloside in RPMI1640 media. All dilutions were done in this
keratinocyte-conditioned medium (CM). Cells were incubated for 3 days at 37uC before performing a nonradioactive cell proliferation assay. Data are
represented as the mean 6 SEM of triplicate determinations. ***, p,0.001.
doi:10.1371/journal.pone.0025480.g004
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12C]aniline. The
labeled mixture of disaccharides was combined with 25 pmol each
of disaccharide standards labeled with [
13C]aniline, and the
sample was subjected to mass spectrometry. Radiometric analysis
of the 12C-and 13C-labeled disaccharides provided a quantitative
way to determine the level of each disaccharide.
In vitro keratinocyte wound assay
The capacity of normal human keratinocytes to migrate, and
close a defined area of injury to a confluent monolayer in vitro was
evaluated by a previously reported assay [11,23]. Primary human
keratinocytes (NHEK) were stimulated with DS (2 mM) alone,
FGF-10 (10 ng/mL) alone, C-Xyloside (1 mM) alone, DS and
FGF-10, C-Xyloside and FGF-10. PBS was used as a vehicle
control (untreated cells). The same fields were photographed every
24 hours, and the area migrated over by keratinocytes was
calculated using Image J Software (NIH Image). The percent
migration at 24 hours was calculated by subtracting the total area
of the scratched at 24 hours from the total area at 0 hour, divided
by the total area at 0 hour multiplied by 100. Images of the areas
were collected with an Olympus MVX10 microscope equipped
with a DC71 camera (Olympus, Center Valley, PA). This
experiment was repeated three times, and the mean of all three
experiments are shown.
Cellular proliferation assay
BaF/KGFR cells were selected as previously described [7]. To
collect cultured media, primary keratinocytes were treated with or
without C-Xyloside (1 mM) in RPMI1640 for 24 hours. All
dilutions of GAG preparations and cells were done in this
keratinocyte-conditioned medium. Before experiments, BaF/
KGFR cells were washed three times in PBS before seeding cells
at a final concentration of 10000 cells/well. Experiments were
conducted in 96-well plates (Costar, Fisher Scientific, Pittsburgh,
PA) with a final volume of 100 ml/well. FGF-10 were used at a
final concentration of 5 ng/ml. Cells were incubated for 3 days at
37uC before performing a nonradioactive cell proliferation assay
(MTT assay, ChemiconH international, Millipore, Billerica, MA).
Statistical analysis
One-way or Two-way ANOVA was used to determine
significance in the experiments in vitro, which were analyzed by
GraphPad Prism 4 (GraphPad Software, Inc.).
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